Display Settings:

Format

Send to:

Choose Destination
    Int J Gynecol Pathol. 2006 Apr;25(2):173-5.

    Myxoid leiomyosarcoma of the uterus in a patient receiving tamoxifen therapy: a case report.

    Source

    Second Department of Obstetrics and Gynecology, University of Athens, Areteion University Hospital, Athens, Greece.

    Abstract

    In this paper, we present a case of myxoid leiomyosarcoma development in a patient receiving tamoxifen for 3 years because of breast cancer. The myxoid leiomyosarcoma should be included in the differential diagnosis of any uterine tumor with a predominantly myxomatous composition. A review of the literature indicates that tamoxifen may increase not only the risk for endometrial cancer but also for uterine sarcoma, suggesting vigilance for uterine cancer in women who are being treated with this drug.

    PMID:
    16633068
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk